OccamzRazor
PrivateLast Round
Series A
Mar 8, 2022
Total Funding Raised
$12M
Company Overview
OccamzRazor operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in March 2022.
OccamzRazor is a digital biotechnology company that uses artificial intelligence and machine learning to discover and develop treatments for complex diseases of brain aging, with a focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, NLP & Conversational AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OccamzRazor Comparables
Compare OccamzRazor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DeepCure | 84% | |
| Model Medicines | 83% | |
| Verge Labs | 83% |
For institutional investors. Book with your work email.
OccamzRazor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 8, 2022 | ||||
| Seed | Oct 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OccamzRazor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Series A |
| re.Mind Capital | Series A |
| Bioverge | Seed, Series A |
| Techammer | Seed |
| Valor Equity Partners | Series A |
| Lanx Capital | Seed |
| Lauder Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 212% MoM, reaching 799.
- Apr 21, 2026
Monthly visitors increased 771% MoM, from 66 to 575.
For institutional investors. Book with your work email.
OccamzRazor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OccamzRazor's valuation, stock price, and market status.
Is OccamzRazor a public or private company?
OccamzRazor is a private company.
What is the current stock price of OccamzRazor?
OccamzRazor is a private company, so its shares have no public market price. Caplight tracks OccamzRazor's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OccamzRazor worth (valuation)?
Valuation information for OccamzRazor is not publicly available.
Can I buy OccamzRazor stock?
OccamzRazor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OccamzRazor's last funding round?
OccamzRazor's most recent funding round was Series A on March 8, 2022.
Who are the main investors in OccamzRazor?
Key investors in OccamzRazor include Gaingels, re.Mind Capital, Bioverge, Techammer, Valor Equity Partners.
Will OccamzRazor IPO soon?
No public IPO plans have been announced for OccamzRazor.
How can I track OccamzRazor secondary market activity?
Caplight tracks bids, offers, and trades in OccamzRazor's shares on secondary markets.